In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront,a TAAR1/5-HT1A Receptor Agonist for the Treatment of Schizophrenia |
| |
| Authors: | Xiao Guangqing Chen Yu-Luan Dedic Nina Xie Linghong Koblan Kenneth S. Galluppi Gerald R. |
| |
| Affiliation: | 1.DMPK and Clinical Pharmacology, Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA
; |
| |
| Abstract: | Pharmaceutical Research - Ulotaront (SEP-363856) is a TAAR1 agonist with 5-HT1A agonist activity currently in clinical development for the treatment of schizophrenia. The objectives of the current... |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
